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Abstract
Background—Prenatal alcohol exposure can result in varying degrees of neurodevelopmental 
deficits, growth retardation, and facial dysmorphology. Variation in these adverse outcomes not 
only depends on the dose and pattern of alcohol exposure but also on less well understood 
interactions among environmental, genetic, and maternal factors. The current study tested the 
hypothesis that fetal genotype is an important determinant of ethanol teratogenesis by evaluating 
effects of ethanol exposure via embryo culture in three inbred strains of mice known to differ in 
the vulnerability of prenatal alcohol exposure in vivo.
Methods and results—Three strains of mice, C57BL/6N (B6), DBA/2 (D2), and 129S6/
SvEvTac (129S6) were assessed in a whole embryo culture beginning on embryonic day 8.25 
(E8.25), with or without alcohol administration at 88mM for 6 hours followed by 42 hrs culture in 
ethanol-free media. Contrasting strain differences in susceptibility were observed for the brain, the 
face, and other organ systems using the Maele-Fabry and Picard scoring system. The forebrain, 
midbrain, hindbrain, heart, optic vesicle, caudal neural tube, and hindlimbs of the B6 mice were 
severely delayed in growth, whereas compared to the respective controls, only the forebrain and 
optic vesicle were delayed in the D2 mice, and no effects were found in the 129S6 mice. A large 
number of cleaved(c)-caspase3 positive (+) cells were found in regions of the brain, optic vesicles, 
cranial nerve nuclei V, VII, VIII, and IX as well as the craniofacial primordial; only a few were 
found in corresponding regions of the B6 controls. In contrast, only a small number of c-caspase 
3-im cells were found in either the alcohol-treated or the controls of the D2 embryos and in 129S6 
embryos. The independent apoptotic markers TUNEL and Nile blue staining further confirmed the 
strain differences in apoptotic responses in both the neural tube and craniofacial primordia.
Conclusions—Under embryo culture conditions, in which alcohol exposure factors and fetal 
developmental staging were controlled, and maternal and intrauterine factors were eliminated, the 
degree of growth retardation and the extent and type of neurodevelopmental teratogenesis varied 
significantly across strains. Notably, the 129S6 strain was remarkably resistant to alcohol-induced 
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growth deficits, confirming a previous in vivo study, and the D2 strain was also significantly less 
affected than the B6 strain. These findings demonstrate that fetal genotype is an important factor 
that can contribute to the variation in fetal alcohol spectrum disorder.
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fetal alcohol syndrome; embryo culture; mouse inbred strains; apoptosis
INTRODUCTION
The prevalence of fetal alcohol syndrome (FAS) (Ernhart et al., 1989, Jones and Smith, 
1973, Stratton et al., 1996, Streissguth et al., 1991) is estimated to be about 1 per 1000 
(Abel, 1995, Sampson et al., 1997, Stratton et al., 1996). Considering all children with 
alcohol-related neurodevelopmental disorder, regardless of whether they show the facial 
dysmorphology needed for the diagnosis of FAS, the prevalence of fetal alcohol spectrum 
disorder (FASD) may be as high as 1 per 100 (Sampson et al., 1997, Hoyme et al., 2005). 
Only about 5–10% of women who drink heavily during pregnancy give birth to children 
diagnosed with FAS (Abel, 1995; Stratton et al., 1996). Variability in functional deficits in 
cognitive, motor, social and emotional behavior are also evident across the spectrum of fetal 
alcohol disorders, with substantial individual differences in the severity of these effects 
(Jacobson et al., 1998, Streissguth et al., 1994, Streissguth et al., 1998). Why are some 
offspring of women who abuse alcohol during pregnancy severely affected, whereas others 
are not? To answer this question, it is important to understand the factors that contribute to 
the risk of prenatal alcohol-induced birth defects and neurodevelopmental disorder. 
Substantial evidence shows that one crucial factor is the variation in the alcohol exposure of 
the fetus resulting from differences in maternal drinking, i.e., quantity, frequency, pattern, 
timing, and duration of drinking during pregnancy (Abel and Hannigan, 1995, Coles, 1993, 
Jacobson et al., 1998, Maier and West, 2001). Another key factor is the developmental stage 
of the embryo or fetus at the time of alcohol exposure, which can determine the major 
outcomes of alcohol exposure, e.g., alcohol exposure during a relatively narrow temporal 
window on the seventh day of pregnancy in mice can induce craniofacial dysmorphology 
that models the craniofacial phenotype of FAS (Sulik et al., 1986).
In addition to variation in the dose, pattern, and timing of prenatal alcohol exposure, genetic 
differences have also been broadly implicated as important contributors to individual 
differences in FASD phenotypes (Riley and Lochry, 1982). However, the understanding of 
genetic contributions to the variation in alcohol-induced teratogenesis has been relatively 
limited to date. Genetic sources of variation in risk include effects related to differences in 
maternal genotype as well as differences in fetal genotype. Maternal factors, including 
maternal genetics, can influence the susceptibility to alcohol-induced fetal growth deficits 
and teratogenesis (Gilliam and Irtenkauf, 1990). Genetic differences in maternal alcohol 
metabolizing enzymes, e.g., alcohol dehydrogenase (ADH) isozymes, influence the risk for 
FAS (McCarver et al., 1997). Fetal genotype has also been implicated in the risk for FAS in 
a twin study (Streissguth and Dehaene, 1993), in that monozygotic twins were fully 
concordant for diagnosis (5 MZ twin pairs) whereas concordance for diagnosis of the 
dizygotic twins was 7/11. However, experimental analysis of genetic and environmental 
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factors is difficult in human studies because the alcohol exposure pattern cannot be 
controlled or manipulated experimentally, and actual alcohol exposure can only be estimated 
from drinking histories obtained in self-reported interviews.
Animal model studies, in which alcohol exposure can be manipulated and genetic and 
environmental factors can be controlled, have also implicated maternal and fetal genetic 
differences in susceptibility to adverse effects of prenatal alcohol exposure. For example, 
effects of offspring genotype have been implicated by evidence of differences in behavioral 
outcomes in selected lines of alcohol preferring (P) and non-preferring (NP) rats (Riley et 
al., 1993) and in high alcohol sensitive (HAS) and low alcohol sensitive (LAS) rats 
following early neonatal alcohol exposure directly to the pups (Thomas et al., 2000). Mouse 
models have been commonly used for studies of morphological damage induced by ethanol, 
particularly for teratogenic effects induced by high ethanol concentrations (Becker et al., 
1996), and differences in effects among inbred strains of mice have been reported in various 
in vivo models. The C57BL/6 (B6) inbred strain consistently shows severe alcohol-related 
teratogenic effects, including fetal mortality, growth deficits, and skeletal, craniofacial, limb, 
kidney, ocular and CNS embryopathic malformations, when dams are given acute doses of 
5–6 g/kg per day during the organogenesis period. Effects on the brain and behavior have 
also been reported in studies in which pregnant B6 dams consume alcohol in a liquid diet 
(Becker et al., 1996). In contrast, certain inbred strains, such as the DBA/2 (D2) strain, are 
significantly less susceptible (Boehm et al., 1997, Downing and Gilliam, 1999) or 
differentially respond to the teratogenic effects of ethanol in embryo culture models in 
which alcohol concentrations are controlled at equivalent levels between strains (Ogawa et 
al., 2005).
A recent study comparing the effects of alcohol (5.8 g/kg via maternal gavage on gestational 
day 9) in five different inbred strains of mice (Downing et al., 2009) reported that the 
129S6/SvEvTac (129S6) strain was highly resistant to fetal weight deficits and 
malformations of the digit, kidney, brain ventricle, and vertebrae, effects that were 
significant in B6 mice. This study supports the contention that genetic differences among 
inbred strains critically determine the risk for teratogenesis, and comparisons between the 
pathogenesis mechanisms of susceptible strains (e.g., B6 mice) and resistant strains (e.g., 
129S6 or D2 mice) can yield important insights into the genetic influences on prenatal 
alcohol-induced teratogenesis.
Whether the effects are mediated through maternal differences (including maternal 
genetics), through differences in prenatal (intrauterine) environmental factors, through fetal 
genetic differences, or combined effects from all three sources is a critical issue concerning 
the genetic contributions to the risk for alcohol-induced birth defects, even when comparing 
across different inbred strains. The present study tested the hypothesis that fetal genotype 
per se can contribute to the variability in alcohol-induced teratogenesis, by comparing the 
more vulnerable B6 inbred strain with the more resistant 129S6 and D2 inbred strains. We 
used an embryo culture model to assess the teratogenic effects of a 6 hour binge-like alcohol 
exposure initiated on embryonic (E) day 8.25 using culture methods that could closely 
match both the developmental staging and the alcohol exposure conditions for all embryos. 
Embryo culture eliminated the potential strain differences in the maternal factors and 
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intrauterine environment that are inherent with in utero exposure models and controlled the 
developmental staging of embryos that is difficult to achieve with in utero models even with 
carefully timed matings due to within- and between-litter variability in embryonic growth 
(Ogawa et al., 2005). The present study tested the prediction—derived from the findings of 
Downing et al. (2009)—that B6 embryos would show more severe alcohol-induced 
teratogenic outcomes than 129S6 or D2 embryos, both in terms of deficits in growth and 
morphology of the brain and somatic structures and in terms of the markers of alcohol-
induced cell death (expression cleaved caspase-3; Nile blue staining; terminal 
deoxynucleotidyl transferase dUTP nick end labeling; (TUNEL) labeling of apoptotic cells).
MATERIALS AND METHODS
Whole Embryo Culture
All experimental procedures were approved by the Institutional Animal Care and Use 
Committee of the Indiana University School of Medicine (Indianapolis, IN) and are in 
accordance with the guidelines of the Institutional Animal Care and Use Committee of the 
National Institute on Drug Abuse, National Institutes of Health, and the Guide for the Care 
and Use of Laboratory Animals (National Academy Press, 1996).
The 12–14 week old C57BL/6N mice (average 20g) and DBA/2 mice (average 20g) were 
purchased from Harlan, Inc (Indianapolis, IN), and the 129S6/SvEvTac mice of similar age 
were purchased from Taconic Farm. Upon arrival, males were individually housed, while 5 
females were housed together and were acclimated for at least one week prior to mating. 
Mice were maintained on a reverse 12:12 light: dark cycle (lights off at 0900), with ad 
libitum chow and water at 22°C room temperature, 30% humidity, in the Indiana University 
Laboratory Animal Research Center vivarium. Females were placed with one male for 2 hrs 
for mating, and vaginal plugs were checked after the mating period. When a plug was 
detected, it was designated as gestational day 0 (GD0) or embryonic day 0 (E0). On E8.2, 
animals were killed by CO2 overdose and cervical dislocation. Uteruses were dissected out 
and removed. Decidual tissues and the Reichert membrane were removed carefully, leaving 
the visceral yolk sac and a small piece of the ectoplacental cone intact. To align the 
developmental stage, only embryos bearing 3–5 somites were used in the study.
Immediately after isolation from uteri, they were placed into a sterile container with 75% 
centrifuged heat inactivated rat serum (Harlan Sprague-Dawley, Inc., Indianapolis, IN) and 
25% PB1 (137 mM NaCl, 2.7 mM KCl, 0.5 mM MgCl 2, 8 mM Na2HPO4, 1.47 mM 
KH2PO4, 0.9 mM CaCl, 5.6 mM glucose and 0.33 mM sodium pyruvate; pH 7.4), with 
penicillin and streptomycin (20 units/ml and 20 microgram/ml, respectively; Sigma, St. 
Louis, MO). Containers were placed on a rotating culture system (B.T.C. Precision 
Incubator Unit; B.T.C. Engineering, Cambridge, England; 36 rpm) at 37°C and gassed with 
5% O2, 5%CO2and 90% N2 for the first 24 hrs, and 20% O2, 5%CO2, and 75% N2 for the 
rest. After pre-culture for 1–2 hrs, all embryos of all strains were randomly assigned to 
either an alcohol treatment condition or a control (no-alcohol) condition. Embryos in the 
alcohol treatment condition were transferred into a medium containing 6 μl/ml of 95% 
ethanol and exposed for 6 hrs. We had previously determined that the media alcohol 
concentration was ~400mg/dL at the beginning of the treatment, and after 12 hrs (i.e., twice 
Chen et al. Page 4
Alcohol Clin Exp Res. Author manuscript; available in PMC 2015 May 27.
Author M
anuscript
Author M
anuscript
Author M
anuscript
Author M
anuscript
longer in this study), it declined to ~300mg/dL, with no differences in the media alcohol 
concentration between B6 and D2 embryonic cultures (Ogawa et al., 2005). This target 
media alcohol concentration (peak ~400 mg/dL) is very similar to the blood alcohol 
concentration produced in dams following the intubation treatment (350–450 mg/dL) used 
by Downing and colleagues (Downing et al., 2009). The control group was cultured in the 
medium with no ethanol. The present study used a 6 hr alcohol exposure in culture, rather 
than the 44 hr exposure of the Ogawa et al. (2005) study, for two reasons. The 6 hr exposure 
allows a more precise analysis of the developmental time period in which various 
teratogenic effects can be induced, allowing a more precise analysis of temporal windows of 
vulnerability. In addition, the 6 hr exposure better matches a single episodic binge exposure 
in vivo that can facilitate comparisons to in vivo treatments at the same developmental 
period.
After the 6 hr alcohol treatment, culture media were disposed and changed back to alcohol-
free culture media for both the control and treatment group. On day 2, embryos were 
transferred to fresh alcohol-free media 24 hrs after the initial culture. All the cultures were 
terminated 44 hrs after the initial culture (8.2+2). Yolk sacs were then opened, and embryos 
were fixed in 4% PFA at 4°C.
Morphological Scoring
A previously described morphological scoring system was used to quantitatively assess the 
morphological features of the mice embryos. The scoring system was adapted from Brown 
and Fabro (1981) and Van Maele-Fabry and Picard (1990) (Brown and Fabro, 1981, Van 
Maele-Fabry et al., 1992), and used in our previous report (Ogawa et al., 2005). The yolk-
sac circulation, heart, caudal neural tube, forebrain, midbrain, hindbrain, otic system, optic 
system, branchial bars, forelimb, hindlimb and somites were individually scored, and a total 
score was given as a sum above the individual scores.
Non-parametric statistics were used for the morphological scoring (embryonic growth) 
analysis because the scores represented an ordinal classification scale. Kruskal-Wallis 
analysis, followed up by Dunn’s post hoc tests, was used to test the strain differences in the 
total morphology score. Mann-Whitney U tests were used to test differences in each ROI 
between the control and alcohol-treated embryos of each strain. Group numbers were as 
follows: C57BL/6: Control n=12, Alcohol n=11; DBA/2: Control n=12, Alcohol n=9; 
129S6/SvEvTac: Control n=7, Alcohol n=8. P-values of 0.05 and 0.01 (indicated by * and 
**, respectively) were used to indicate the degree of statistical significance. Statistics were 
performed using Prism Software Version 4 (GraphPad Software. Inc., San Diego, CA).
Immunocytochemistry
A monoclonal antibody against the specific form of intermediate apoptosis marker, cleaved-
caspase-3 (c-caspase 3; activated form, cleaved adjacent to Asp175; Cell Signaling 
Technology, Danvas, MA, USA) was used which specifically recognizes the cleaved 18-
kDa subunit of active caspase 3 and does not recognize the 32-kDa procaspase or other 
cleaved caspase3 (Olney, 2004). This antibody has been characterized by the preabsorption 
of antigenic peptide which completely blocked the ability of the antibody to recognize the 
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active c-caspase 3 in rat cerebellar cortices (Oomman et al., 2004). We have also performed 
a secondary antibody control in which the absence of the c-caspase 3 antibody resulted in 
negative staining. Further, the distribution of c-caspase 3-positive staining was found to be 
similar to that of apoptosis staining with Nile blue at the cranionucleus level (Dunty et al., 
2002). In our immunocytochemical procedure, the alcohol-treated and the control embryos 
were embedded together in a single gelatin block and were carefully aligned by their level 
and orientation. Then, they were cut into 40μm sections using Leica VT 100S vibrating 
microtome and then processed free-floating in the same vial. They were treated equally in all 
aspects of the immunocytochemical processing from this point onwards. This practice 
avoids any bias through the staining procedure and is convenient for comparing levels of 
embryo sections side by side. Sections were incubated with 3% H2O2 in 0.1M phosphate 
buffered saline (PBS, PH7.4) for 10 min, washed in PBS, and then incubated in 1% Triton-
X-100 in a phosphate buffer overnight. Sections were preincubated in PBS containing 
0.1%Triton-X, 1.5% normal goat serum for 90 min before incubation with anti-c-caspase-3 
antibody (Rabbit polyclonal, 1:150, Cell signaling, Beverly, MA) overnight. The next day, 
sections were washed three times in PBS and then incubated with a biotin-conjugated Goat-
anti-Rabbit secondary antibody (1:500, Jackson ImmunoResearch Lab, West Grove, PA) for 
90 min. Sections were rinsed in PBS and then incubated in peroxidase-conjugated 
streptavidin (1:500, Jackson ImmunoReseach Lab, West Grove, PA) for 60 min. The PAP 
reaction was performed with 0.003% H202 and 0.05% 3′ 3-diaminobenzidine (Sigma, St. 
Louis, MO) for 10 min. The primary, secondary, and third antibodies were diluted in PBS 
containing 0.1% Triton X-100 and 1.5% normal goat serum. All procedures were done at 
room temperature. All sections were Nissl-counterstained with methyl green to reveal 
background cells to identify embryo structures.
Nile Blue Vital Staining
Nile blue (NB) staining was performed to stain apoptotic nuclei, which are seen in cells that 
died by apoptosis. B6 and 129S6 embryos (n=4–5 pairs of control and alcohol-treated) were 
examined at around E10.2. Nile blue (1:10,000 in PBS, Sigma, St. Louis, MO) was placed 
into culture media 2 hrs before the culture ended (Kotch and Sulik, 1992). Embryos free of a 
yolk sac were stained for 2 hrs at 37°C, followed by a washing in PBS for 15 min, and then 
fixed in 4% PFA. Both alcohol-treated and control embryos were processed simultaneously, 
allowing for an accurate comparison of patterns of cell death. Photographs were taken 
immediately after fixation under stereomicroscope (Leica MZFLIII). NB staining 
distributions were comparable to previous NB staining in embryos by Dunty et. al. (Dunty et 
al., 2002).
TUNEL Staining
TUNEL (Terminal deoxynucleotidyl transferase dUTP nick end labeling) staining labeling 
DNA strand breaks was performed to detect apoptotic cells. TACS™ 2TdT-DAB in situ 
Apoptosis Detection Kit (Trevigen, Gaithersburg, MD) was used. Gelatin- embedded 
embryo sections were prepared as above. Staining was performed following the kit’s 
instructions. In brief, tissue sections were permeablized with proteinase K (1:200) for 30 
min at room temperature, followed by incubation in 3% hydrogen peroxide in PBS for 5 min 
to quench endogenous peroxidase. Then, a labeling reaction mix (containing dNTP mix 
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1:50, cation buffer, TdT enzyme 1:50 in labeling buffer) was applied at 37°C for 1 hr, 
followed by washing with a stop buffer and transferring to strep-HRP solution for 10 min at 
37°C. Sections were then washed in PBS, developed for coloration in peroxidase substrate 
with 0.05% DAB and 0.03% H202, and counterstained with methyl green. A positive control 
treated with DNase (TACS-Nuclease, 1:50, Trevigen, Gaithersburg, MD) was included in 
each experiment, which also indicates the specificity and sensitivity of TUNEL labeling.
Quantification of c-caspase 3+ and TUNEL+ Cells
The assessment for c-caspase 3 + cells and TUNEL+ cells were measured by staining 
density using NIH imaging (Bethesda, MD). Images were taken using a Leitz Orthoplan II 
microscope and a high-resolution SPOT2 camera (under 6.3X or 10X, depending on the size 
of structures measured, in a bright field). All the images were taken under the same setup 
with the same exposure time. The density of immuno-labeled or TUNEL-labeled cells in a 
specific tissue area was compared between the alcohol treated group and the control group 
in three different mice strains. Images were converted into 16-bit color in ImageJ. A 
threshold value was set up to eliminate noise from the signal and to subtract the background. 
The same value was applied consistently to all the images. Signals above the threshold in 
ROI (region of interested) were measured by integrated density using the ImageJ analysis 
tool. The density value of consecutive sections was added up and constituted the region of 
interest. The total 14 regions of embryos between the alcohol and control groups were 
measured according to The Atlas of Mouse Development (M.H. Kaufman, 1992), including 
the central nerves system, peripheral nerves system, cardiac system, limbs and somites. For 
c-caspase 3 staining analysis, data were analyzed using two-way ANOVA with the treatment 
group and strain as between-subjects factors. C57BL/6: n=5; DBA/2: n=5; 129S6/SvEvTac: 
n=5. The significance of the treatment effects were followed up with a Bonferroni post hoc 
test. In addition, using Tukey’s post hoc test, one-way ANOVAs were used as a follow-up 
comparison among controls of three strains of embryos. An alpha level of 0.05 was used to 
assess significant results. For TUNEL staining analysis, a t-test was used for a comparison 
between alcohol treated and control embryos. C57BL/6: n=4; 129S6/SvEvTac: n=3. Data 
are presented as Mean ± standard error means (SEM). All statistics were performed using 
Prism Software Version 4 (GraphPad Software. Inc., San Diego, CA).
RESULTS
Growth Delay Analysis
The basal development of the three strain embryos was similar as indicated by the Brown 
and Fabro (1981) and Van Maele-Fabry and Picard (1990) growth scoring system; there was 
no difference on the total score of the Control embryos among the three strains (P>0.05, 
Kruskal-Wallis test). In contrast, the total scores of the Alcohol-treated embryos were 
significantly different among strains (Kruskal-Wallis value =7.803, p<0.05). The overall 
score indicated that there was a significant alcohol-induced delay of B6 and D2 embryos 
relative to their controls, with greater delay in B6 mice; the 129S6 mice showed no evidence 
of alcohol-induced growth delay (Table 1, Mann-Whitney U tests). For B6 mice, the growth 
rate was significantly retarded in the Alcohol-treated group as compared to the Controls, and 
significant reductions were seen in the heart (Table 1), fore-, mid-, and hind-brain, caudal 
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neural tube, optic vesicle, and hindlimb (Figure 1A, B). For the D2 mice, alcohol-induced 
growth delay was seen only in the forebrain and optic vesicle (Figure 1C). In contrast, the 
129S6 mice demonstrated remarkable resistance to alcohol exposure; no significant growth 
delay was observed (Figure 1D).
Apoptosis Analysis
Assessing from different levels, the three apoptosis analyses, the cleaved caspase 3, 
TUNEL, and Nile blue agreed on differential apoptotic vulnerability across the strains:
a. Cleaved Caspase 3—In B6 Control, the c-caspase 3 positive (+) cells appeared 
sporadically in the fore-, mid-, and hindbrain, clustered in low density in the trigeminal (V) 
ganglia, facial (VII) and acoustic (VIII) ganglion complex, glossopharyngeal (IX) and vagus 
(X) nerve ganglion, and dorsal root ganglia between somite 5 and 28. In the Alcohol-
exposed B6 group, a vast increase of c-caspase 3+ cells were seen throughout the fore-, 
mid-, and hindbrain, except for the frontal pole of the forebrain (Figure 2A, B). Thus, the 
increase of c-caspase 3+ cells was not only in the area of natural apoptosis [e.g. cranial 
nucleus V, VII–VIII, & IX–X, and DRG and associated somites (Figure 2C, D)], but also in 
new brain regions that do not normally show apoptosis [e.g., a distinct group of c-caspase 3+ 
cells was prominent along the midline (Figure 2B)]. Noticeable increases of c-caspase 3+ 
cells were also seen at rhombomere (r) 1 and r2 that appear in the rostral and ventral 
subventricular zone of the fourth ventricle. Other than brain regions, the c-caspase 3+ cells 
also increased in the heart. Importantly, the craniofacial regions are keys to distinguishing 
the strain difference in differential apoptosis. In the B6 mice, alcohol increased c-caspase 3+ 
cells in the forehead region and branchial arches I and II of the Alcohol-treated groups as 
compared with Controls (Figure 3).
In 129S6 Control, fewer c-caspase 3+ cells were found as compared with those of B6. 
Alcohol did not significantly increase c-caspase 3+ cells in most of the brain or craniofacial 
areas, except for the three cranial nuclei V, VII and VIII, where a modest increase was seen 
and measured (Figure 2I–L).
Similarly, in D2 Controls significantly fewer c-caspase 3+ cells were seen as compared with 
those of B6 Controls. Alcohol did not induce a detectable increase in c-caspase 3+ cells in 
the D2 embryos, except in the heart (Figure2E–H). Craniofacial c-caspase 3+ cells were not 
significantly increased by alcohol treatment either in D2 or in S129S mice.
A quantification of c-caspase 3 staining optic density in the above regions is shown in 
Figure 4. Two-way ANOVA showed a significant interaction among the three strains and 
treatment in cranial nuclei V [F(2, 23)=3.973, P<0.05], VII & VIII [F(2, 17)=5.533, 
P<0.05)], IX & X [F(2, 23)=8.715, P<0.01)], heart [F(2, 23)=4.45, P<0.05], rhombomere 
(r1–r2) [F(2, 23)=3.654, P<0.05)], 1st branchial arch [F(2, 17)=4.838, P<0.05], and optic 
vesicle [F(2, 23)=5.032, P<0.05)], indicating significant differential effects of alcohol 
treatment on these three strains. Strain comparisons indicated that in B6 embryos, significant 
differences between the alcohol and control groups were seen in the heart, forebrain, and 
caudal neural tube, as well as the craniolfacial regions, including trigeminal (V) nucleus, VII 
& VIII, and IX & X nuclei, and otic vesicle (Figure 4). In D2 embryos, only the heart 
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(P<0.02) showed a significant difference between the alcohols and controls. In 129S6 
embryos, cranial nerve nuclei V (P<0.05) and VII–VIII (P<0.05) showed significant 
differences. When comparing B6 with 129S6 using a two-way ANOVA, significant alcohol 
treatment x strain interactions were shown in nucleus VII–VIII [F(1,11)=11.16, P<0.01], 
cranial nucleus IX–X [F(1,11)=20.33, P<0.005], heart [F(2,15)=5.51, P<0.05], rhombomere 
(r1–r2) [F(2, 15)=5.680, P<0.05], optic vesicle [F(2,15)=19.22, P<0.005], and 1st branchial 
arch [F(1,11)=5.821, P<0.05]. Likewise, when comparing B6 with D2, VII–VII 
[F(1,11)=6.266, P<0.05], IX& X [F(1,11)=7.561, P<0.05], and heart [F(1,11)=5.311, 
P<0.05] showed significant alcohol treatment x strain interactions, indicating the effects of 
alcohol identified in these regions depended on the two fetal genotypes. However, there was 
no significant interaction of alcohol treatment x strain when comparing D2 and 129S6 
strains in any of the above regions except for the caudal neural tube. Furthermore, one-way 
ANOVA for Controls of all the three strains showed only one region with a significant 
difference, the midbrain [F(2, 10)=5.97, P<0.05]. This suggests there were few baseline 
differences in c-caspase 3 expression across D2 and 129S6 strains. In contrast, one-way 
ANOVAs for the alcohol groups of the three strains showed significant strain differences in 
most of the regions.
b. Nile Blue—Nile blue vital staining was performed in the two contrast strains, B6 and 
129S6.
In B6 mice, at about E10.25, the telencephalic vesicles and fourth ventricle were well 
differentiated; a scattered pattern of moderately stained Nile blue positive (NB+) cells was 
observed at this stage in the forebrain and midbrain in the control embryo. Ethanol treatment 
resulted in a significant increase in NB staining with more NB+ cells evident in the regions 
identified above (Figure 5). Specifically, a dramatic increase in the dorsal midline of the 
forebrain was consistently seen (Figure 5D).
Cranifacial features including distinct first and second branchial arches, migrating neural 
crest cells, and cranial nerve ganglia are visible through NB staining. More NB+ staining 
was present along the proximal rim of the mandibular prominence and second branchial 
arch, and at the junction between maxillary and mandibular prominence. This is consistent 
with a previous report (Dunty et al., 2002). In the cranial nuclei, increased Nile blue uptake 
was observed in the cranial nuclei V, VII & VIII, and IX, and neural crest cells migrating to 
the third branchial arch. Furthermore, an increase of NB uptake from moderate or no 
staining to heavy staining were found in the olfactory placode, peripheral boundaries of the 
olfactory pit, optic vesicles, and Rathke’s pouch of alcohol exposed embryos as compared to 
their counterparts in the controls. Particularly, an excessive increase of NB uptake was seen 
in the optic stalk of the alcohol group. Also at this stage, NB staining was seen mostly in 
somite regions rostral as well as the caudal to forelimb, i.e. somites 5–7 and 9–13. The 
forelimb region always takes up dye in both the control and ethanol-treated embryos, though 
the ethanol-treated embryo showed more uptake in the distal end of the forelimb. Also, 
where severe malformation was found in the caudal neural tube, Nile blue was also 
intensified at the region including lower limbs.
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In 129S6 mice, overall NB uptake was less than that in B6 mice in both the control and 
ethanol-treated embryos. No increase of staining or number of NB+ staining in the fore- 
mid- or hindbrain was seen in the alcohol-treated group as compared to the 129S6 controls. 
Maximal Nile blue uptake was observed in the forebrain midline, olfactory pit, mandibular 
prominence of the first branchial arch, forelimb, and rostral somites. Mild increase of NB 
staining could be seen in cranial nuclei V, VII & VIII., olfactory placode surrounding the 
pit, maxillary and mandibular prominence after alcohol treatment (Figure 5G–M).
c. TUNEL staining—Confirmation of the caspase 3 for apoptosis with TUNEL staining 
was demonstrated in B6 and 129 embryos (Figure 6 and Table 2) as compared with caspase3 
(Figures 2 and 3). In B6 embryos, an overall significant increase of TUNEL positive cell 
was seen in the forebrain (P<0.001, t-test, N=4) and midbrain (P<0.05), as well as 
cranialfacial features, including V (P< 0.01), VII–VIII cranial nuclei (P<0.005), 1st 
branchial arch (P<0.01). The somites and dorsal root ganglia at the level of forelimb 
(P<0.05) also showed more TUNEL positive cells in alcohol-treated embryos as compared 
to those of Controls (Figure 6C, D). In 129S6 embryos, most of the above regions do not 
show significant increase of TUNEL+ cells, except VII–VIII cranial nuclei (P<0.05) (Table 
2).
DISCUSSION
The major goal of the current study was to determine whether fetal genotype is an important 
determinant of susceptibility to prenatal alcohol-induced birth defects. We tested the 
hypothesis that previously identified strain differences in teratogenesis (Downing et al., 
2009), resulting from heavy in utero alcohol exposure, would be replicated by binge-like 
alcohol exposure directly to the embryos via embryonic culture. As predicted from the in 
utero models showing significant and severe alcohol-induced growth deficits and structural 
malformations (fetal weight deficits and kidney, brain ventricle, and vertebral 
malformations) (Downing et al., 2009), the present study confirmed major alcohol-induced 
teratogenesis in the B6 mice and further demonstrated that apoptotic cell death was evident, 
together with significant growth retardation, in many brain regions, craniofacial structures, 
the heart, and the neural tube. The present study also confirmed that the 129S6 mice were 
remarkably resistant to alcohol-related growth deficits, and the D2 strain showed alcohol-
induced growth deficits only in the forebrain and optic regions. This study provides new 
evidence that alcohol-induced apoptotic cell death was also greatest in the B6 strain, 
whereas the 129S6 strain showed significant increases in c-caspase 3+ cells only in cranial 
nerve nuclei V, VII and VIII, and the D2 strain showed no evidence of alcohol-induced 
increase in c-caspase 3 expression.
These differences in the extent of alcohol-induced teratogenesis in embryo culture provide 
conclusive evidence that fetal genotype is an important contributor to susceptibility to 
alcohol-related teratogenesis. Embryo culture allows control over major non-genetic factors 
including alcohol exposure variables and alignment of the developmental stage at the time of 
exposure, and it eliminates maternal physiology, metabolism, and genetics, along with other 
sources of non-genetic variation (e.g., intrauterine environment). In this model system, 
significant strain differences in outcomes can be directly attributed to genetic differences 
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between the strains. Moreover, the alcohol exposure was clinically relevant in that it models 
a single heavy binge exposure at the time of neurulation that was limited to six hours and 
was comparable across the three inbred strains. These differences in embryonic effects in a 
pharmacologically relevant exposure provide a useful model to pursue a systematic search 
for genes (or alcohol-regulated gene expression) in the embryos that impart relatively 
susceptibility or resistance to the teratogenic effects of alcohol. Although the effects 
reported here reflect effects of a single exposure at a relatively high concentration in an 
embryo culture model that lacks potentially important maternal and intrauterine effects that 
may be critical for effects on alcohol effects in vivo, these findings do predict that strain 
differences in the dose-response of growth deficits and of adverse outcomes on brain and 
behavioral deficits would be evident between the B6 and 129S6 strains.
Differential Dysmorphology
The current study confirmed that the embryonic growth deficits induced by the 6 hr alcohol 
treatment differed significantly among the inbred strains, with more retardation in the mid- 
and hindbrain, caudal neural tube, heart, and optic vesicle in B6 than D2 or 129S6 mice. The 
differences between B6 and D2 mice are consistent with our previous study that used a 44 hr 
alcohol treatment (Ogawa et al., 2005), though the 44 hr alcohol treatment of that study did 
produce a delay in heart formation in D2 mice—an effect not observed with the 6 hr 
exposure of the current study. The current results indicate that the 6 hr binge-like alcohol 
exposure at the beginning of neurulation is critical in causing delays in growth of many of 
the above organ structures. Furthermore, 6 hrs of alcohol exposure at this early embryonic 
stage was sufficient to reveal the differential effects on growth among the three strains. In 
particular, the 129S6 was resistant to the 6 hr alcohol exposure of the current high dose of 
alcohol; since that strain was not included in the previous study, we do not have data from a 
more prolonged alcohol exposure (44 hrs) to assess the impact of a longer duration of 
exposure. Our current findings showing major teratogenesis in the B6 mice and relatively 
limited effects in the 126S6 mice are also in agreement with the findings of Downing and 
colleagues (Downing et al., 2009), who reported that administration of 5.8 g/kg ethanol via 
gavage to pregnant dams on E9 caused extensive teratogenesis, including fetal weight 
deficits and kidney, brain ventricle, and vertebral malformations in B6, but not in 129S6.
Though the presence of c-caspase 3, an active form of caspase 3, does not necessarily 
indicate final cellular commitment to apoptosis [e.g., antibody may detect caspase 9-like 
component (Fan and Bergmann, 2010)], it has been compared with TUNEL with good 
fidelity in detecting programmed cell death (Duan et al., 2003). Our study indicated that the 
c-caspase 3 has good correlation with Nile blue (Figure 2, 3, and 5) and TUNEL staining 
(Figure 2, 3, and 6) in early development. The severe alcohol-induced apoptosis found in the 
brain regions, heart, limb, somite, and dorsal root ganglia in B6 embryos, compared to the 
much lesser degree in 129S6 or D2 embryos, demonstrated differential vulnerability of the 
three strains to alcohol exposure. Besides the above regions where growth delay occurred 
(e.g. forebrain, midbrain, heart), additional evidence of extensive apoptosis in B6 but not in 
D2 strains was present in the brain midline, craniofacial region (including forehead, and 
first, second, and third branchial arches), truncal dorsal root ganglia, and in major cranial 
nuclei (V, VII, and VIII). The 129S6 strain showed an increase of apoptosis in V, VII and 
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VIII cranial nuclei but not in other regions. To the extent this apoptosis reflects or predicts 
enduring reductions of the cells within an organ, it supports the findings of growth delays in 
the corresponding regions, e.g. fore-, mid-, and hind-brain, and would also contribute to the 
facial dysmorphology and neurodevelopmental deficits that are diagnostic for FAS.
Strain Considerations
Although the genetic differences among the inbred strains that underlie the differential 
vulnerability are yet to be investigated, given the striking contrast in susceptibility to 
alcohol-induced teratogenesis, it is interesting to note the three stains are derived from 
diverse backgrounds. The B6 and D2 strains are well known for their extensive genetic and 
phenotypic differences. B6 mice are generally referred to as alcohol-preferring and D2 as 
alcohol-avoiding (Le et al., 1994). They differ not only in their alcohol drinking propensity 
but also in response to alcohol and cocaine stimulation (Fish et al., 2010, De Waele et al., 
1992) and their insulin secretion in response to a high fat diet (Andrikopoulos et al., 2005). 
The current study adds the embryonic vulnerability to alcohol to the catalogue of differences 
between B6 and D2 mice.
The B6 and D2 strains are widely used and the 129S6 strain to lesser degree in alcohol-
related studies or in other research studies, yet generalization of effects, including 
teratogenic effects, from studies of a few inbred strains can only be made with caution. For 
example, teratogenic effects observed with inbred strains are often either limited when 
assessed in genetically heterogenous stocks or show dominance toward resistance to 
teratogenic effects in outbred crosses (Gilliam et al., 1988, Gilliam and Irtenkauf, 1990). In 
addition, comparison of differences involving only a few inbred strains are inadequate to 
assess genetic correlations of various phenotypes; for example, the B6 and D2 strains not 
only differ in alcohol preference and resistance to alcohol’s teratogenic effects but also in 
the rate of progression through development staging. Inferences concerning genetically 
correlated phenotypes cannot be made from comparisons of only a few inbred strains, but 
the clear demonstration of strain differences in embryos of these three strains does provide a 
starting point for more mechanistic studies of genetically-based susceptibility and resistance.
The 129S6 (129S6/SvEvTac) strain, which was recently characterized with respect to fetal 
alcohol vulnerability (Downing et al., 2009), is derived from a congenic strain made by out 
crossing to introduce the Steel mutation. The expression of the Steel locus is essential for 
normal development of three populations of stem cells: the neural crest-derived 
melanoblasts, germ cells, and blood cell precursors (Keller et al., 1990). All existing 129 
mouse inbred substrains have a 25bp deletion in exon 6 of Disc1 (disrupted in schizophrenia 
1) gene (Clapcote and Roder, 2006) which induces a frame shift in the reading frame of 
Disc1, resulting in 13 novel amino acids, followed by a premature stop codon. It is unclear if 
such deletion affects neuronal characteristics. There are currently more than 15 substrains of 
the 129 lines, and a large degree of genetic diversity has been identified among the 129 
substrains (Simpson et al., 1997). The apoptotic resistance and invulnerability of 129S6/
SvEvTac to alcohol exposure should not be generalized with the other 129 substrains yet.
Another point of interest in light of current finding is that virtually all embryonic stem (ES) 
cell lines for gene targeting are derived from substrains of the 129S6 mouse. It is highly 
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likely these stem cells would be subject to similar resistance. Researchers using these three 
strains of mice for studies of plasticity and developmental studies must be cautious in 
keeping the current finding in mind.
Mechanistic Consideration
The mechanisms behind the differential embryonic vulnerability are unknown. There are no 
significant differences in gene expression of alcohol dehydrogenases (ADH), catalase, and a 
number of the cytochrome P450 enzyme family between B6 and D2 mice; aldehyde 
dehydrogenase 2 (ALDH2) and aldehyde dehydrogenase 1A1 (ALDH1A1) are higher in D2, 
whereas aldehyde dehydrogenase 7A1 (ALDH7A1) is higher in B6 (Bhave et al., 2006). 
One report indicated that hepatic and brain catalase activities were two- to three-fold higher 
in adult D2 than in adult B6 mice (He et al., 1997). Alcohol dehydrogenase 3 (ADH3) is a 
major form of alcohol catabolic enzyme in embryonic alcohol metabolism (Duester, 1994). 
Information on the expression of ADH3 in the embryonic B6, D2, and S129S is not yet 
available. If the observed strain differences are related to tissue-specific differences in 
expression of alcohol-metabolizing genes, then filling the gap of knowledge will be an 
important step toward understanding fetal genotype’s risk for FASD.
The current study is the first demonstration that the alcohol-induced differential 
vulnerability of embryos from three different inbred strains of mice could be distinguished at 
the cellular level with differential apoptosis. This is an important step toward a better 
understanding of the cellular mechanisms for differential vulnerability at the genetic level. 
We demonstrated that caspase 3 is not as extensively induced by alcohol in 129S6 and D2 
embryos as compared to B6 embryos. It is possible that 129S6, for example, may not use the 
caspase-dependent pathway for programmed cell death (Momoi et al., 2003), or its caspase-
dependent pathway was less sensitive to alcohol.
Significance and Application
In summary, we found that the binge alcohol exposure at early neurulation resulted in 
strikingly different effects in growth retardation and apoptosis among the B6, D2, and 129S6 
inbred strains. The differential vulnerability was not only evident in the brain and heart, but 
also in the embryonic facial structures, including the maxillary, mandibular arch, olfactory 
placode, and optic vesicle. The varying degrees of vulnerability, ranging from severe to 
partial to none in growth retardation and apoptosis are attributable to genetic differences 
between the strains rather than to the variability in alcohol exposure (amount, concentration, 
pattern, timing, or duration), in the embryonic stage of development or in maternal factors 
(metabolism or intrauterine physiology). This study definitively demonstrates that the fetal 
genotype is an important contributing factor to the risk for birth defects induced by binge-
like alcohol exposure during early neurulation. The variable spectrum of prenatal alcohol-
induced brain abnormalities and facial dysmorphology has been observed in FASD 
populations of different ethnic groups, e.g. Italy, South Africa, and Finland (Ceccanti et al., 
2007). The current observation provides biological evidence and support that the diverse 
response to binge-like prenatal alcohol exposure in altering development of the brain and 
face can depend, in part, on the genotype of the offspring. It is important to identify the 
specific genes that impart susceptibility or resistance to alcohol exposure. Identifying those 
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genes would provide insight into a better understanding of the mechanisms by which alcohol 
causes growth retardation and apoptosis, and it could potentially provide biomarkers for 
individual susceptibility to or resistant against the alcohol insult.
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Figure 1. 
Morphology of control and alcohol-treated embryos (E8.2+2) in three strains: B6, D2 and 
129S6. Neural tube-opening was seen in forebrain, midbrain, hindbrain (A right panel) and 
caudal neural tube of B6 embryo (B, right panel). In contrast, the growth retardation was not 
apparent in D2 (C) or in 129S6 (D) as compared between their Control and alcohol-treated 
embryos respectively. FB: forebrain; MB: midbrain; HB: hindbrain; CNT: caudal neural 
tube; HL: hindlimb. Scale bar: A–C=300μm.
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Figure 2. 
The Contrast expression of c-caspase 3 + cells upon alcohol treatment in B6 (A–D), versus 
D2 (E–H) and 129S6 (I–L) E8.2+2 embryos. Midsagittal sections (A, B) showed a vast 
increase of c-caspase 3 + cells in alcohol-treated embryos throughout fore-, mid-, and hind-
brain, cranial nucleus V, VII–VIII, X, and dorsal root ganglia cells along with somites (C, 
D). An increase of c-caspase 3+ cells was seen prevalent at the midline along forebrain (A, 
B, arrow). A noticeable increase of c-caspase 3+ cells was seen at the rostral and ventral sub-
ventricular zone of the 4th ventricle (A, B, arrowheads). A similar distribution of c-caspase 
3+ cells in control B6 was seen in the D2 and 129S6 control. No noticeable increase of c-
caspase 3+ cells was seen in most parts of the brain in alcohol-treated D2 and 129S6 as 
compared to their respective control groups, except for a minor increase in cranial nuclei V 
and VII& VIII cranial nerve cells of alcohol-treated 129S6 (J, arrow). FB: Forebrain; MB, 
midbrain; HB: hindbrain; NT: neural tube. Scale bar: A–L=100μm.
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Figure 3. 
Distribution of c-caspase 3+ cells in craniofacial and metencephalic regions of B6, D2 and 
129S6 embryos in para-sagittal section. Alcohol-treatment increased extensively the caspase 
level and number of c-caspase 3+ cells in the local structure of these regions in B6 (A, B). 
Higher magnification of boxed region in B showing significant increase of c-caspase 3+ 
cells in cranial nuclei VII& VIII cranial nerve cells in alcohol-treated embryo was shown in 
D. Scale Bar: A, B=100μm, C–H=100μm.
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Figure 4. 
Semi-quantification of c-caspase 3+ cells in B6, D2 and 129S6 embryos. 12 ROIs were 
included: left panels showing brain, heart, caudal neural tube and somites; right panels 
showing craniofacial features of each strain. N=5, *P <0.05, data presented as Mean ± SEM. 
Major increase of caspase distribution density was seen in B6. Significant alcohol effects 
were present only in the heart of D2, and cranial nuclei of S129S6.
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Figure 5. 
Nile Blue (NB) staining was increased in eye, olfactory pit, midbrain, otic stalk, 1st and 2nd 
branchial arch, VII&VIII nerve- and IX, X cranial nerve nuclei of alcohol treated B6 as 
compared to its control (A, B). A conspicuous increase of NB staining was shown in midline 
of forebrain of alcohol treated B6 embryo (D, arrowhead), similar to that of c-caspase 3 
(Figure 2); an increase in NB was also seen in somites at level of forelimb (E, F). No 
apparent difference of NB staining was seen in the 129S6 control and alcohol embryo (G–
M). Arrowhead: forebrain midline (D, K) and dorsal root ganglia in somites (E, F). Olf.: 
olfactory pit. Scale bar: A–M=100μm.
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Figure 6. 
The TUNEL staining is shown here with similar distribution to that of c-caspase 3 (Figure 2 
and 3) in the B6 and 129S6 embryos. More TUNEL+ cells were found in alcohol-treated (B, 
D) than those in Control embryo (A, C). Higher magnification of boxed region in A and B 
was shown in E and F respectively, indicating more TUNEL+ cells in cranial nuclei V, VII, 
& VIII, and in first and second branchial arches after alcohol treatment. Scale bars: A, B, C, 
D= 100μm; E, F=100μm.
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Table 2
TUNEL staining quantification in B6 and 129S6 E8.2+2 embryos.
B6 129S6
Control Alcohol Control Alcohol
Forebrain 55.14±16.87 181.69±17.98 ** 43.25±7.83 59.41±16.13
Midbrain 51.62±13.24 130.14±28.81 * 47.93±10.95 71.07±28.50
Hindbrain 106.26± 36.78 169.81±28.73 21.57±4.64 45.70±23.51
Cranial n. V. 65.53±4.03 118.98±34.28 11.48±3.46 38.37±27.30
VII–VIII 17.00±4.03 111.21±4.91 ** 8.77±1.29 61.66±13.89 *
Branchial Arch 15.39±3.45 84.14±12.80 * 5.71±8.67 7.19±2.57
Heart 34.69±11.24 244.37±132.21 6.15±1.62 9.77±4.37
somites 64.85±10.50 369.70±72.34 * 95.70±38.35 88.56±22.36
*
P<0.05 compare to control
**
P<0.005 compare to control.
B6: n=4; 129S6:n=4
Data presented as Mean ± SEM.
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